The New Brunswick, N.J.-based drugmaker first announced the split into two independent companies in November 2021. This year, J&J tapped Thibaut Mongon as the consumer health company’s CEO and Larry Merlo, the former president and CEO of CVS, as a chairman.
The name “is inspired by two powerful ideas: ‘ken’ — meaning knowledge, an English word primarily used in Scotland, and ‘vue,’ referencing sight,” according to J&J.
Last year, J&J’s consumer health business — which makes brands including Band-Aid, Tylenol, Neutrogena and Listerine — accumulated $14.6 billion in revenue. Its pharmaceutical division made $52 billion and its medical device side made $27 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
